Phase I Trial of THE-0504 in Solid Tumors Initiated
A phase I clinical trial is underway to assess the safety and tolerability of THE-0504 in patients with solid tumors.
Asset / Drug
Drug and asset intelligence for THE-0504 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.